Zoetis Inc. (NYSE:ZTS - Get Free Report) EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $151.17, for a total value of $139,529.91. Following the sale, the executive vice president now directly owns 14,800 shares in the company, valued at $2,237,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Roxanne Lagano also recently made the following trade(s):
- On Monday, March 18th, Roxanne Lagano sold 923 shares of Zoetis stock. The shares were sold at an average price of $173.33, for a total value of $159,983.59.
- On Monday, February 12th, Roxanne Lagano sold 363 shares of Zoetis stock. The stock was sold at an average price of $197.74, for a total value of $71,779.62.
Zoetis Stock Performance
NYSE ZTS opened at $153.11 on Friday. Zoetis Inc. has a 52-week low of $148.48 and a 52-week high of $201.92. The company has a 50-day simple moving average of $176.49 and a 200 day simple moving average of $180.20. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.00 and a current ratio of 3.36. The company has a market capitalization of $70.03 billion, a PE ratio of 30.20, a price-to-earnings-growth ratio of 2.32 and a beta of 0.85.
A.I. is a Tidal Wave - Here’s What to Buy
From Chaikin Analytics | Ad
The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone.
Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.
Get the name and ticker symbol for free - just click here.
Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.32 by ($0.08). Zoetis had a net margin of 27.43% and a return on equity of 51.25%. The company had revenue of $2.21 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the firm earned $1.15 earnings per share. The company's revenue for the quarter was up 8.5% compared to the same quarter last year. On average, research analysts predict that Zoetis Inc. will post 5.79 EPS for the current year.
Zoetis Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be paid a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date is Thursday, April 18th. Zoetis's payout ratio is 34.12%.
Analyst Ratings Changes
Several equities analysts have recently commented on the stock. Stifel Nicolaus lowered their price target on shares of Zoetis from $215.00 to $195.00 and set a "buy" rating on the stock in a report on Tuesday, April 2nd. Piper Sandler reaffirmed an "overweight" rating and set a $195.00 price objective (down from $220.00) on shares of Zoetis in a research note on Tuesday. Barclays raised their price objective on shares of Zoetis from $255.00 to $260.00 and gave the company an "overweight" rating in a research note on Wednesday, February 14th. StockNews.com cut shares of Zoetis from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, February 20th. Finally, The Goldman Sachs Group boosted their price objective on shares of Zoetis from $190.00 to $226.00 and gave the stock a "buy" rating in a research note on Wednesday, January 17th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $221.75.
Read Our Latest Analysis on Zoetis
Hedge Funds Weigh In On Zoetis
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Blue Bell Private Wealth Management LLC increased its holdings in Zoetis by 222.5% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company's stock worth $25,000 after acquiring an additional 89 shares in the last quarter. Evermay Wealth Management LLC grew its holdings in Zoetis by 439.3% during the 1st quarter. Evermay Wealth Management LLC now owns 151 shares of the company's stock valued at $25,000 after buying an additional 123 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its holdings in shares of Zoetis by 430.8% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company's stock valued at $26,000 after purchasing an additional 112 shares in the last quarter. Worth Asset Management LLC purchased a new position in shares of Zoetis in the first quarter valued at $26,000. Finally, Webster Bank N. A. grew its holdings in shares of Zoetis by 89.1% in the first quarter. Webster Bank N. A. now owns 174 shares of the company's stock valued at $29,000 after purchasing an additional 82 shares in the last quarter. Institutional investors own 92.80% of the company's stock.
Zoetis Company Profile
(
Get Free Report)
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
